BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22278227)

  • 21. HCV immunology--death and the maiden T cell.
    Willberg C; Barnes E; Klenerman P
    Cell Death Differ; 2003 Jan; 10 Suppl 1():S39-47. PubMed ID: 12655345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.
    Bhanja Chowdhury J; Shrivastava S; Steele R; Di Bisceglie AM; Ray R; Ray RB
    J Virol; 2012 Sep; 86(18):10221-5. PubMed ID: 22787204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct effects of hepatitis C virus on the lymphoid cells.
    Kondo Y; Shimosegawa T
    World J Gastroenterol; 2013 Nov; 19(44):7889-95. PubMed ID: 24307783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication.
    Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S
    Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
    Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
    J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell recognition of hepatitis B and C viral antigens.
    Jung MC; Diepolder HM; Pape GR
    Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load.
    Westhaus S; Deest M; Nguyen ATX; Stanke F; Heckl D; Costa R; Schambach A; Manns MP; Berg T; Vondran FWR; Sarrazin C; Ciesek S; von Hahn T
    J Hepatol; 2017 Aug; 67(2):237-245. PubMed ID: 28363797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1.
    Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
    Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
    Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.
    Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM
    J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients.
    Zignego AL; De Carli M; Monti M; Careccia G; La Villa G; Giannini C; D'Elios MM; Del Prete G; Gentilini P
    J Med Virol; 1995 Sep; 47(1):58-64. PubMed ID: 8551260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood mononuclear cells serve as a possible extrahepatic site for hepatitis C virus replication.
    Mahran MZ; Elalim AA; Abbas A
    Egypt J Immunol; 2009; 16(2):63-70. PubMed ID: 22059354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.
    Steinmann D; Barth H; Gissler B; Schürmann P; Adah MI; Gerlach JT; Pape GR; Depla E; Jacobs D; Maertens G; Patel AH; Inchauspé G; Liang TJ; Blum HE; Baumert TF
    J Virol; 2004 Sep; 78(17):9030-40. PubMed ID: 15308699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy.
    Li W; Krishnadas DK; Li J; Tyrrell DL; Agrawal B
    J Immunol; 2006 May; 176(10):6065-75. PubMed ID: 16670315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication.
    Cimini E; Bordoni V; Sacchi A; Visco-Comandini U; Montalbano M; Taibi C; Casetti R; Lalle E; D'Offizi G; Capobianchi MR; Agrati C
    Virus Res; 2018 Jan; 243():31-35. PubMed ID: 29029951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.
    Pal S; Sullivan DG; Kim S; Lai KK; Kae J; Cotler SJ; Carithers RL; Wood BL; Perkins JD; Gretch DR
    Gastroenterology; 2006 Apr; 130(4):1107-16. PubMed ID: 16618405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
    Bhattarai N; McLinden JH; Xiang J; Mathahs MM; Schmidt WN; Kaufman TM; Stapleton JT
    PLoS Pathog; 2017 Feb; 13(2):e1006232. PubMed ID: 28235043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.